Delivery Order SPE2DB22D1202-SPE2DB24FVDQ8
- Not listed
- This federal contract award is for the delivery of LOTREL 10-20 MG CAPSULE 100S to the Defense Logistics Agency (DLA). The contract has a ceiling value of $19,585.71 and is a Firm Fixed Price Delivery Order. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of September 17, 2024 and was awarded on September 16, 2024. The contract was not set aside for any specific business...
- This federal contract award is for the delivery of LOTREL 10-20 MG CAPSULE 100S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $13,460.19 fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, with an ultimate completion date of August 29, 2024. The contract was awarded under the DLA's Troop Support Medical Indefinite Delivery Contract, a large medical commodities vehicle valued up to $999,999,999 through December 2025,...
- The U.S. Defense Logistics Agency (DLA) awarded a $1,890.68 Firm Fixed Price delivery order contract to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract is for the supply of 4,565,295,981 units of the drug Lotrel 10-20 mg capsules in 100-count packages. The contract has a period of performance through July 31, 2024. AmerisourceBergen holds several Indefinite Delivery Contracts (IDCs) with DLA Troop Support Medical and the Department of Justice Federal Bureau...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The $1,023.63 firm fixed-price delivery order is for the supply of 100 capsules of the medication Lotrel 5-10 mg. The contract has an ultimate completion date of July 14, 2025 and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite...
- This federal contract award is for the delivery of LOTREL 10-20 MG CAPSULE 100S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., which is a major pharmaceutical distribution company. The contract, valued at $2,462.96, is a delivery order with a firm fixed price. It has an ultimate completion date of March 11, 2024. The contract is not associated with any set-aside...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is a $20,494.59 Firm Fixed Price Delivery Order contract with the Defense Logistics Agency (DLA) to supply 4565286155 LOTREL 10-20 MG CAPSULE 100S. The award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through December 2025 between Amerisourcebergen and the DLA Troop Support Medical for delivering a comprehensive range of pharmaceutical and medical supplies to support...
- This federal contract award, valued at $25,362.67, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order (DO) for LOTREL 10-20 MG CAPSULE 100S, a cardiovascular medication. The contract has a Firm Fixed Price (FFP) pricing type and an ultimate completion date of December 18, 2023. This award is not associated with a set-aside program and is part of a larger Indefinite...
- This federal contract award, valued at $12,202.61, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for 4560714047 LOTREL 5-20 MG CAPSULE 100S, with an ultimate completion date of April 26, 2023. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026....
- The Defense Logistics Agency (DLA) awarded a $10,580.70 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of LOTREL 10-20 MG CAPSULE 100S. This contract is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for providing a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. The...
- This is a federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., by the Defense Logistics Agency (DLA). The contract is for the delivery of Lotrel 5-20 mg capsules, a cardiovascular medication, with a ceiling value of $1,324.36 and a completion date of April 14, 2023. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- SPE2DB22D1202Indefinite Delivery Contract
- SPE2DB22D1202-SPE2DB24FVDQ8Delivery Order
This federal contract award is for the delivery of LOTREL 5-20 MG CAPSULE 100S pharmaceutical products to the Defense Logistics Agency (DLA), a defense agency. The award, valued at $1,942.32, was made to the Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of June 17, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The company also holds a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000 through May 2024.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.9k | 6/14/24 |